Sign Up For Free
Exploring other cannabinoids
In addition to the two most studied cannabinoids, THC and CBD, there are over 60 other cannabis molecules that have been isolated by researchers. While the list of clinical applications for particular cannabinoids remains short – CBG, CBC, CBN, and a handful of others – the prospect that others will produce therapeutic results is promising.
Cannabigerol is a non-psychoactive cannabinoid that, similar to CBD, doesn’t possess any known psychotropic properties. Where CBG differs most drastically from the two cannabinoids outlined above, is in the proficiency of the plant’s trichomes to produce the compound. On average, CBG is only found in extremely low levels in almost all cannabis strains, though it serves, significantly, as the parent chemical of both CBD and THC.1 
Cannabichromene is yet another non-psychoactive cannabinoid, and one that has garnered an increase in interest among researchers and the medical cannabis community at large. A significant, yet enigmatic, cannabinoid that has yet to fully be studied or understood, some researchers believe CBC could one day rival CBD as one of the primary components isolated from the cannabis plant for medical purposes.
Cannabinol is present in only miniscule amounts in the cannabis flower, and is factually a breakdown of THC – something of an aged version of the plant’s primary psychoactive component. Because of the sedative nature of CBN, strains high in THC can often contribute to features such as drowsiness, which can obviously work for, or against, an effective cannabis treatment plan.
In addition to these five primary components, cannabis trichomes also produce in the area of about 115 other cannabinoids. The study of nearly all but those mentioned above, and a few others with obscure, but promising, names like THCv and CBDv, remain a mystery to most. And still one reality has become a welcome certainty, that as research around these chemicals grows, so too does the prospect of discovering the key to the plant’s next miracle.
  1. “Cannabinoid pharmacology: the first 66 years.” https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1038/sj.bjp.0706406

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.